PL1654284T3 - Sposób uzyskiwania roztworu alfa-1-antytrypsyny - Google Patents

Sposób uzyskiwania roztworu alfa-1-antytrypsyny

Info

Publication number
PL1654284T3
PL1654284T3 PL04764046T PL04764046T PL1654284T3 PL 1654284 T3 PL1654284 T3 PL 1654284T3 PL 04764046 T PL04764046 T PL 04764046T PL 04764046 T PL04764046 T PL 04764046T PL 1654284 T3 PL1654284 T3 PL 1654284T3
Authority
PL
Poland
Prior art keywords
a1at
alpha
obtaining
detergents
antitrypsin solution
Prior art date
Application number
PL04764046T
Other languages
English (en)
Polish (pl)
Inventor
Petra Schulz
Jürgen Römisch
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Octapharma Ag filed Critical Octapharma Ag
Publication of PL1654284T3 publication Critical patent/PL1654284T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/16—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/022—Filtration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/04—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8125—Alpha-1-antitrypsin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
PL04764046T 2003-08-12 2004-08-12 Sposób uzyskiwania roztworu alfa-1-antytrypsyny PL1654284T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49409703P 2003-08-12 2003-08-12
EP04764046A EP1654284B1 (en) 2003-08-12 2004-08-12 Process for preparing an alpha-1-antitrypsin solution
PCT/EP2004/009043 WO2005014648A1 (en) 2003-08-12 2004-08-12 Process for preparing an alpha-1-antitrypsin solution

Publications (1)

Publication Number Publication Date
PL1654284T3 true PL1654284T3 (pl) 2009-09-30

Family

ID=34135316

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04764046T PL1654284T3 (pl) 2003-08-12 2004-08-12 Sposób uzyskiwania roztworu alfa-1-antytrypsyny

Country Status (22)

Country Link
US (1) US20060194300A1 (https=)
EP (1) EP1654284B1 (https=)
JP (1) JP4668904B2 (https=)
KR (1) KR20060070543A (https=)
CN (1) CN1867582B (https=)
AT (1) ATE428730T1 (https=)
AU (1) AU2004262578B2 (https=)
BR (1) BRPI0412835A (https=)
CA (1) CA2534900A1 (https=)
DE (1) DE602004020632D1 (https=)
DK (1) DK1654284T3 (https=)
ES (1) ES2324168T3 (https=)
IL (1) IL172868A0 (https=)
NO (1) NO20060109L (https=)
PL (1) PL1654284T3 (https=)
PT (1) PT1654284E (https=)
RS (1) RS20060077A (https=)
RU (1) RU2370500C2 (https=)
SI (1) SI1654284T1 (https=)
UA (1) UA86775C2 (https=)
WO (1) WO2005014648A1 (https=)
ZA (1) ZA200601206B (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1664123E (pt) * 2003-09-22 2008-07-16 Kamada Ltd Preparação em larga escala de um inibidor da alfa-1 proteinase e sua utilização
ES2246694B1 (es) 2004-04-29 2007-05-01 Instituto Cientifico Y Tecnologico De Navarra, S.A. Nanoparticulas pegiladas.
ES2246695B1 (es) 2004-04-29 2007-05-01 Instituto Cientifico Y Tecnologico De Navarra, S.A. Composicion estimuladora de la respuesta inmunitaria que comprende nanoparticulas a base de un copolimero de metil vinil eter y anhidrido maleico.
CN100354301C (zh) * 2005-10-13 2007-12-12 南京工业大学 化学合成多肽的新型大规模分离制备技术
CN100562523C (zh) * 2006-07-26 2009-11-25 河北大安制药有限公司 α1-抗胰蛋白酶的制备方法
PL2214699T3 (pl) 2007-11-02 2017-05-31 Grifols Therapeutics Inc. Sposób, kompozycja i wyrób do dostarczania alfa1-antytrypsyny
CN102127165B (zh) * 2010-01-15 2013-09-04 上海莱士血液制品股份有限公司 一种从血浆组分四沉淀中制备高纯ApoA-I的生产工艺
CN102731642B (zh) * 2011-04-14 2014-01-29 上海莱士血液制品股份有限公司 从人血浆组分四沉淀制备高纯Apoa-I的生产工艺
US9353165B2 (en) * 2012-07-25 2016-05-31 Grifols, S.A. Purification of cell culture derived alpha1 protease inhibitor
AU2013205138B2 (en) * 2012-08-09 2015-06-25 Grifols, S.A. Caprylate Viral Deactivation
MY179524A (en) 2015-06-26 2020-11-10 Ferring Bv Methods of purification and/or viral inactivation
AU2017214678B2 (en) * 2016-02-03 2024-02-01 Plasma Technologies, Llc Methods for extracting proteins from a blood-based material
ES2991988T3 (es) 2017-10-30 2024-12-05 Takeda Pharmaceuticals Co Detergentes compatibles con el medio ambiente para la inactivación de virus con envoltura lipídica
CN111991571B (zh) * 2020-08-12 2022-04-05 湖州师范学院 一种柱上低pH病毒灭活的方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS584728A (ja) * 1981-05-01 1983-01-11 メデイカル・リサ−チ・インステイチユ−ト・オブ・サンフランシスコ・コ−ポレ−シヨン α−１−抗トリプシンの精製
US4379087A (en) * 1982-06-17 1983-04-05 Cutter Laboratories, Inc. Method of preparing alpha-1-proteinase inhibitor
US4684723A (en) * 1985-09-11 1987-08-04 Miles Laboratories, Inc. Method of separating proteins from aqueous solutions
US4629567A (en) * 1986-03-07 1986-12-16 Smithkline-Rit Alpha-1-antiprotease purification
EP0288841B1 (en) * 1987-04-27 1992-12-30 Miles Inc. Method of preparing highly purified alpha-1-proteinase inhibitor
KR920005689B1 (ko) * 1989-12-21 1992-07-13 국제약품공업주식회사 혈청으로부터 알파-1-안티트립신의 분리 정제 및 혈중 알파-1-안티트립신 양의 검정키트
DE4125625C2 (de) * 1991-08-02 1999-12-02 Octapharma Ag Glarus Verfahren zur Herstellung von virusinaktivierten Immunglobulinlösungen
SE9301582D0 (sv) * 1993-05-07 1993-05-07 Kabi Pharmacia Ab Purification of plasma proteins
DE4407837C1 (de) * 1994-03-09 1995-08-17 Octapharma Ag Verfahren zur Gewinnung von hochreinem, virusinaktiviertem alpha¶1¶-Antitrypsin mittels Anionenaustauscher-Chromatographie
US6284874B1 (en) * 1994-06-17 2001-09-04 Alpha Therapeutic Corporation Process for separating α1-proteinase inhibitor from cohn fraction IV1 and IV4 paste
AU6884396A (en) * 1995-09-07 1997-03-27 Ppl Therapeutics (Scotland) Ltd Purification of alpha-1 proteinase inhibitor
JP4105249B2 (ja) * 1996-08-09 2008-06-25 財団法人化学及血清療法研究所 α２プラスミンインヒビターの製造方法
AT407114B (de) * 1997-06-10 2000-12-27 Immuno Ag Alpha 1-antitrypsin-präparation sowie verfahren zu deren herstellung

Also Published As

Publication number Publication date
CA2534900A1 (en) 2005-02-17
DK1654284T3 (da) 2009-07-20
ZA200601206B (en) 2007-05-30
UA86775C2 (ru) 2009-05-25
US20060194300A1 (en) 2006-08-31
NO20060109L (no) 2006-02-15
RU2006107533A (ru) 2006-07-27
JP2007523883A (ja) 2007-08-23
RS20060077A (sr) 2008-08-07
AU2004262578B2 (en) 2010-05-06
RU2370500C2 (ru) 2009-10-20
BRPI0412835A (pt) 2006-09-26
KR20060070543A (ko) 2006-06-23
EP1654284A1 (en) 2006-05-10
AU2004262578A1 (en) 2005-02-17
PT1654284E (pt) 2009-07-06
SI1654284T1 (sl) 2009-10-31
DE602004020632D1 (de) 2009-05-28
CN1867582B (zh) 2010-06-16
ATE428730T1 (de) 2009-05-15
WO2005014648A1 (en) 2005-02-17
ES2324168T3 (es) 2009-07-31
JP4668904B2 (ja) 2011-04-13
IL172868A0 (en) 2006-06-11
EP1654284B1 (en) 2009-04-15
CN1867582A (zh) 2006-11-22

Similar Documents

Publication Publication Date Title
PL1654284T3 (pl) Sposób uzyskiwania roztworu alfa-1-antytrypsyny
EA200201012A1 (ru) Способы стерилизации биологических материалов
PT813541E (pt) Processo de producao de uma proteina
WO2002096457A3 (en) Stable liquid formulations of antibodies
TW200505480A (en) High concentration antibody and protein formulations
EA200200249A1 (ru) Производные 3(5)-уреидопиразола, способ их получения и их применение в качестве противоопухолевых агентов
CO5580776A2 (es) Formulacion farmaceutica estable en solucion de oxaliplatino
DK1475101T3 (da) Antistof-holdige farmaceutiske opløsninger
RU95108231A (ru) Glp-1-молекулярный комплекс, фармацевтическая композиция и способ получения комплекса
NO20045070L (no) Fremgangsmate for a frembringe en 2-18F-fluor-2-deoksy-D-glukose(18F-FDG)-losning
WO2004037784A3 (en) Pyrrolidones with anti-hiv activity
BR0307236A (pt) Processo para fabricação de compostos orgânicos
PE103799A1 (es) Procedimiento de purificacion de mesilato de alatrofloxacino
IL177286A0 (en) Albumin-purification method comprising a nanofiltration step, solution, and composition for therapeutic use containing same
EP1831239B8 (en) A process for the preparation of 17-hydroxy-6 beta, 7 beta, 15 beta, 16 beta -bismethylene-17 alpha-pregn-4-ene-3-one-21-carboxylic acid gamma-lactone and key-intermediates for this process
ATE374022T1 (de) Oxaliplatinlösungskonzentrate
AR035808A1 (es) Proceso de deshidratacion capaz de minimizar la epimerizacion de un grupo hidroxilo por ciertas equinocandinas
WO2004037853A3 (en) Quinolones with anti-hiv activity
MY146013A (en) Process for purifying mesotrione
BRPI0407448A (pt) Processo quìmico
EA200800785A1 (ru) 4-арил-1,4-дигидро-3(2н)-изохинолиноны и 4-арил-1,2,3,4-тетрагидроизохинолины в качестве ингибиторов igf-1r и в качестве фармакологического средства в тест-системах, фармацевтическая композиция и изделие на их основе и способ лечения заболеваний, опосредованных igf-1 рецептором
BRPI0416274A (pt) método para produzir solução de amÈnio de ácido orgánico
IT1265964B1 (it) Micro-granuli ottenuti tramite estrusione-sferonizzazione contenenti una ciclodestrina.
SE9904289D0 (sv) Method and camposition for the treatment of adenovairal ocular infections
DE60325731D1 (en) Monopropylenglykol als fermentationszusatz